Fall Pharma Round-Up: Pricing Scandals Are the Least of Its Worries

, ,

With September’s flurry of media coverage over drug pricing, pharma has a unique opportunity to rescue its spiraling reputation. Wearables, third-party data analytics providers, and commercial operations account management are just a few hot tickets that hold a lot of promise – so does the marriage of Big Data and Big Pharma. Did you miss any of these hot news stories in the past month?

1. The Need for Smart Data

By Adam Hill, published on eyeforpharma

Third-party help: The saviors of analytics?

Are you having a hard time making good use of your data? You’re not alone. Head of AstraZeneca’s Advanced Analytics Center, James Weatherall, purports that there are two key issues the industry is facing: the need for smart data, not big data, and the need for skilled people to generate these insights. With more than a million skilled workers lacking in this segment of the industry alone, Weatherall predicts that data analytics solutions will step in to fill the void.

Read More

2. Why Your Company Needs Data Analytics

By Daniel Burrus, published on LinkedIn

What a leading technology expert has to say about data analytics

Your organization needs data analytics, or so says Daniel Burrus, a leading technology consultant. The amount of data and information is growing at an exponential rate. In this reality, data analytics is the only way to turn all this flood of data into usable insights. Lacking these insights, your business will struggle to improve operations and management. Now that’s a dismal future.

Read More

3. The Rebirth of the Pharma Sales Rep

By James Crowley, published on pharmaphorum

Helping your sales team reinvent themselves in light of market changes

Much was said about the “end of the pharma sales rep role”. But changes in the industry do not have to mark the end, but rather an opportunity for a new beginning. Turns out, ingenuity and innovation will define teams that make it through the next evolution of sales. The way sales teams define and service customers will either drive success or guarantee failure. It all boils down to being responsive and relevant.

Read More

4. 7 Account Management Best Practices That Will Make a Difference

By David Laws, published on eyeforpharma

Is your organization dreaming about account management?

Pharma is taking a cue from other industries employing successful account management for commercial operations, and taking it on as its own. What separates those organizations dreaming of practicing account management and actually doing it? These seven best practices help organizations achieve it.

Read More

5. Big Pharma Hands Out Fitbits to Collect Better Personal Data

By Anna Edney and Caroline Chen, published on BloombergBusiness

Wearables take center stage in drug trials

With almost 300 drug trials testing out wearables to record patient behavior, Fitbit and other devices are helping speed time-to-market. With the amount of personal data collected, pharma organizations are looking to streamline the process and gather improved insights about the drug’s performance. Could wearables be the revolution pharma needs to advance R&D?

Read More

6. Focus on the Fundamentals not the Tools

By Tina Boggiano, published on eyeforpharma

Making good use of wearables

The obsession with wearables has gotten many Pharma companies scrambled and confused as to which tool to develop. According to experts, the way out of this confusion is to change the perspective; stop asking what wearables can do for you, start asking what you can do for patients and providers.

Read More

7. Drugs and the Patient Burden: How Far, How Fast and How Much?

By William Looney, published on PharmaExec.com

The high costs patients shoulder to get drugs

Data show that patients are increasingly beholden to the high costs associated with drug benefits. As pharma becomes more patient-centric, the question remains, how far will this patientricity go? And just how high will deductibles, copays and patient costs will get before something breaks?

Read More

8. A Timeline of the Turing Pharma Controversy

By Luke Timmerman, published on Forbes

Is it over yet?

The drug pricing scandal of September 2015 may go down in history as the biggest yet. Get an inside look at how the move by one pharma CEO got heightened coverage, the attention of Hillary Clinton, and led to plummeting biotech stock prices.

Read More

9. Here’s A Way For Pharma To Prevent Outrageous Generic Price Increases – And Help Its Reputation

By John LaMattina, published on Forbes

How to turn around pharma’s bad rap

Scarred as it is from recent scandals, Pharma needs to find a way out of this black hole of bad moves and negative press, and into the light. How can it get there? In part, it needs to get a handle on generic price increases to ward off future issues like the recent Turing kerfluffle.

Read More

10. Roche CEO: Big Data needs Big Pharma, and vice versa

By Tracy Staton, published on FiercePharma

Here comes pharma’s bride

Do you hear wedding bells? It’s high time that Big Data and Big Pharma got together to scratch each other’s backs. Pharma has realized it needs data; however, the reverse hasn’t necessarily been true. By some estimations, tech companies can only succeed in healthcare if they harness pharma expertise. Then, giants like Google and IBM with their expertise in analyzing data will know how to deliver solutions that solve healthcare problems.

Read More